Clinical Trials Containment Generic Pharmaceutical Regulation 
The Pharma Data
MAY 8, 2021
The global development program for Sandoz’ biosimilar aflibercept was developed in consultation with major regulatory agencies and the results from this clinical study are expected to support regulatory submissions. Eylea ® is a trademark of Bayer AG and in the US of Regeneron Pharmaceuticals, Inc. Disclaimer. About Sandoz.
The Pharma Data
MAY 18, 2021
Sandoz is the global leader in generic antibiotics and operates the only vertically-integrated antibiotic network left in Europe, despite fierce competition from Asia. Disclaimer This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
MAY 2, 2021
The global development program for Sandoz’ biosimilar aflibercept was developed in consultation with major regulatory agencies and the results from this clinical study are expected to support regulatory submissions. Eylea ® is a trademark of Bayer AG and in the US of Regeneron Pharmaceuticals, Inc. Disclaimer. About Sandoz.
The Pharma Data
MAY 15, 2023
For more information on the Sandoz Board of Directors, please also see [link] Disclaimer This media update contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Our ambition is to be the world’s leading and most valued generics company.
XTalks
AUGUST 2, 2023
It contains the antiviral medications nirmatrelvir and ritonavir. In September 2022, Roche acquired Good Therapeutics for an upfront payment of $250 million, and has access to their PD-1-regulated IL-2 program. Clinical trials have shown that the vaccine is 90 percent effective in preventing shingles for individuals aged 50 and over.
Expert insights. Personalized for you.
52 
Let's personalize your content